Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
VenoStent [0]   
[30/01/2024]

VenoStent : VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

VenoStent is conducting a 200subject, prospective, onetoone randomized controlled trial in dialysis accessHOUSTON, TX / ACCESSWIRE / January 30, 2024 / VenoStent, Inc., a clinicalstage, venturebacked, therapeutic medical device company developing bioabsorbable wraps to improve outcomes for hemodialysis patients, has announced enrollment of its first subjects i... Lire le communiqué
 
VenoStent [0]   
[31/07/2023]

VenoStent : VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trial

Breakthrough medical device has shown promise to improve outcomes in dialysis patientsHOUSTON, TX / ACCESSWIRE / July 31, 2023 / VenoStent, Inc., a clinicalstage, venturebacked, therapeutic medical device company developing bioabsorbable wraps to improve outcomes for hemodialysis patients, has announced that they have been granted Investigational Device Exemption... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de VenoSte...